Clinical

Latest News


Latest Videos


More News

David Hafler, MD, chairman of the Department of Neurology at the Yale School of Medicine, spoke of exciting times in the field of genome-wide association study-specifically speaking to neurology, genetics, the environment, and the autoimmune response.

The FDA today granted approval to the programmed death ligand-1 inhibitor, nivolumab (Opdivo), for treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN), following platinum-based treatment.

Obesity is more than just a lifestyle disease. Ted Kyle, RPh, MBA, principal at ConscienHealth, explained that understanding its complexities as well as the behavioral and physical care it requires is essential in improving the health and productivity of employees.